Literature DB >> 24759301

The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin a nephropathy: a randomized controlled trial.

Piyawan Kittiskulnam1, Talerngsak Kanjanabuch2, Kannika Tangmanjitjaroen3, Wiwat Chancharoenthana1, Kearkiat Praditpornsilpa1, Somchai Eiam-Ong1.   

Abstract

OBJECTIVE: This study was conducted to examine the effects of weight reduction on proteinuria, adipokines, and renal function in overweight immunoglobulin A nephropathy (IgAN) patients (body mass index > 23 kg/m2) with chronic proteinuria more than 6 months.
DESIGN: This was a single-center, prospective, randomized controlled trial. The study was performed at the outpatient clinic at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, from July 2012 to February 2013.
SUBJECTS: Twenty-six overweight patients with chronic proteinuric biopsy-proven IgAN were randomized into a control group (n = 13) or a low-calorie normal protein diet group (n = 13). All patients received the maximum dosage of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and other antihypertensive agents to achieve a blood pressure less than 125/75 mmHg. INTERVENTION: The study intervention was a low-calorie diet (target energy per day as 500-kcal subtraction from total energy requirement) for a 6-month period. MAIN OUTCOME MEASURE: At baseline and after 6 months of a low-calorie diet, body weight, body content, and clinical and laboratory parameters were determined and compared.
RESULTS: After initiating a low-calorie diet for 6 months, the normalized protein nitrogen appearance values were not different, indicating comparable protein intake. The low-calorie group had lower total daily calorie intake (1,307.1 ± 171.8 vs. 1,772.2 ± 315.4 kcal/d, P < .01) and significant reductions in body weight (-5.1 ± 3.3%, P < .001), fat content (-12.7 ± 14.1%, P < .05), and 24-hour urine protein (-45.2 ± 15.4%, P < .001). Blood pressure and renal function parameters were unaltered. The low-calorie group had approximately 20% lower plasma levels of leptin but unchanged adiponectin. There were positive correlations between the amount of protein reduction and the changes of body weight, fat mass, and leptin.
CONCLUSIONS: A 6-month low-calorie diet leads to weight reduction and results in diminished fat content and decreased proteinuria in overweight IgAN patients with chronic proteinuria. This beneficial effect might be mediated by changes in adipokines.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759301     DOI: 10.1053/j.jrn.2014.01.016

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  10 in total

Review 1.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

Review 2.  [Pathophysiology and treatment of IgA nephropathy].

Authors:  R Bollin; H Haller
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

3.  Impact of body mass index on primary immunoglobulin A nephropathy prognosis: a systematic review and meta-analysis.

Authors:  Qin Wang; Jian-Jiang Zhang; Wen-Jie Dou; Hui-Qin Zeng; Pei-Pei Shi; Jing Wu
Journal:  Int Urol Nephrol       Date:  2021-08-12       Impact factor: 2.370

Review 4.  Long-term effects of weight-reducing diets in people with hypertension.

Authors:  Thomas Semlitsch; Klaus Jeitler; Andrea Berghold; Karl Horvath; Nicole Posch; Stephanie Poggenburg; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2016-03-02

5.  Interventions for weight loss in people with chronic kidney disease who are overweight or obese.

Authors:  Marguerite M Conley; Catherine M McFarlane; David W Johnson; Jaimon T Kelly; Katrina L Campbell; Helen L MacLaughlin
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

Review 6.  IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Authors:  Arun Rajasekaran; Bruce A Julian; Dana V Rizk
Journal:  Am J Med Sci       Date:  2020-10-08       Impact factor: 2.378

7.  Long-term effects of weight-reducing diets in people with hypertension.

Authors:  Thomas Semlitsch; Cornelia Krenn; Klaus Jeitler; Andrea Berghold; Karl Horvath; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2021-02-08

Review 8.  Emerging Modes of Treatment of IgA Nephropathy.

Authors:  Dita Maixnerova; Vladimir Tesar
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

9.  Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation.

Authors:  Dita Maixnerova; Petra Hruba; Michaela Neprasova; Kamila Bednarova; Janka Slatinska; Miloslav Suchanek; Marek Kollar; Jan Novak; Vladimir Tesar; Ondrej Viklicky
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

10.  Waist Circumference and Body Mass Index Variability and Incident Diabetic Microvascular Complications: A Post Hoc Analysis of ACCORD Trial.

Authors:  Daniel Nyarko Hukportie; Fu-Rong Li; Rui Zhou; Jia-Zhen Zheng; Xiao-Xiang Wu; Xian-Bo Wu
Journal:  Diabetes Metab J       Date:  2022-05-10       Impact factor: 5.893

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.